- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Pacira Pharmaceuticals Inc/DE
+ Add to Watchlist82P:GR
22.529 EUR 0.320 1.44%As of 03:00:43 ET on 05/24/2013.
Snapshot for Pacira Pharmaceuticals Inc/DE (82P)
| Open: | 22.810 | Day's Range: | 22.529 - 22.810 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 22.209 | 52wk Range: | 7.976 - 23.076 | 1-Yr Rtn: | +164.33% |
Key Statistics for 82P
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -1.7000 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 43 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 82P
Company Profile & Key Executives for 82P
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.
| David M Stack "Dave"President/CEO | James S ScibettaChief Financial Officer |
| Gary PatouChief Medical Officer | Taunia MarkvickaVP:Commercial |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
82P News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page